PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

Company profile
Ticker
RVTY, PKI
Exchange
Website
CEO
Prahlad Singh
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Seer • Prenetics Global Limited • Cue Health ...
Former names
EG&G INC, PERKINELMER INC
SEC CIK
Corporate docs
Subsidiaries
2Cure, LLC • BioLegend CNS, Inc. • BioLegend Ventures, LLC • BioLegend, Inc. • Caliper Life Sciences, Inc. • Cambridge Research • Dharmacon, Inc. • Horizon Discovery, Inc. • Immunodiagnostic Systems Inc. • Nexcelom Bioscience Holdings, LLC ...
IRS number
42052042
RVTY stock data
Analyst ratings and price targets
Latest filings (excl ownership)
SD
Conflict minerals disclosure
31 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
8-K
Results of Operations and Financial Condition
11 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
28 Apr 23
8-K
Entry into a Material Definitive Agreement
15 Mar 23
ARS
2023 FY
Annual report to shareholders
8 Mar 23
DEFA14A
Additional proxy soliciting materials
8 Mar 23
DEF 14A
Definitive proxy
8 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Results of Operations and Financial Condition
14 Feb 23
Transcripts
RVTY
Earnings call transcript
2023 Q1
11 May 23
RVTY
Earnings call transcript
2022 Q3
8 Nov 22
RVTY
Earnings call transcript
2022 Q2
5 Aug 22
RVTY
Earnings call transcript
2022 Q1
4 May 22
RVTY
Earnings call transcript
2021 Q4
2 Feb 22
RVTY
Earnings call transcript
2021 Q3
3 Nov 21
RVTY
Earnings call transcript
2021 Q2
29 Jul 21
RVTY
Earnings call transcript
2021 Q1
5 May 21
RVTY
Earnings call transcript
2020 Q4
3 Feb 21
RVTY
Earnings call transcript
2020 Q3
28 Oct 20
Latest ownership filings
4
Samuel R. Chapin
17 May 23
4
ALEXIS P MICHAS
17 May 23
4
Frank Witney
17 May 23
4
Sylvie Gregoire
17 May 23
4
Peter Barrett
17 May 23
4
Michelle McMurry-Heath
17 May 23
4
Michel Vounatsos
17 May 23
4
Pascale Witz
17 May 23
4
Andrew Okun
14 Apr 23
144
Notice of proposed sale of securities
13 Apr 23
Financial summary
Quarter (USD) | Apr 23 | Jan 23 | Oct 22 | Jul 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jan 23 | Jan 22 | Jan 21 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2023
82.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 540 |
Opened positions | 45 |
Closed positions | 99 |
Increased positions | 203 |
Reduced positions | 185 |
13F shares | Current |
---|---|
Total value | 13.70 tn |
Total shares | 102.85 mm |
Total puts | 79.00 k |
Total calls | 57.10 k |
Total put/call ratio | 1.4 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 14.68 mm | $1.96 tn |
Capital Research Global Investors | 11.84 mm | $1.58 tn |
T. Rowe Price Investment Management | 9.97 mm | $1.33 tn |
Select Equity | 9.94 mm | $1.32 tn |
BLK Blackrock | 8.58 mm | $1.14 tn |
STT State Street | 5.19 mm | $691.25 bn |
Citadel Advisors | 3.13 mm | $417.11 bn |
Geode Capital Management | 2.60 mm | $345.46 bn |
Massachusetts Financial Services | 2.29 mm | $304.55 bn |
JHG Janus Henderson | 2.09 mm | $278.77 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 May 23 | Chapin Samuel R. | Common Stock | Grant | Acquire A | No | No | 0 | 955 | 0.00 | 15,789 |
15 May 23 | Chapin Samuel R. | Common Stock | Grant | Acquire A | No | No | 0 | 783 | 0.00 | 14,834 |
15 May 23 | Michas Alexis P | Common Stock | Grant | Acquire A | No | No | 0 | 1,372 | 0.00 | 60,584 |
15 May 23 | Michas Alexis P | Common Stock | Grant | Acquire A | No | No | 0 | 1,061 | 0.00 | 59,212 |
15 May 23 | Witney Frank | Common Stock | Grant | Acquire A | No | No | 0 | 955 | 0.00 | 16,467 |
15 May 23 | Witney Frank | Common Stock | Grant | Acquire A | No | No | 0 | 783 | 0.00 | 15,512 |
15 May 23 | Gregoire Sylvie | Common Stock | Grant | Acquire A | No | No | 0 | 955 | 0.00 | 20,482 |
15 May 23 | Gregoire Sylvie | Common Stock | Grant | Acquire A | No | No | 0 | 783 | 0.00 | 19,527 |
15 May 23 | Barrett Peter | Common Stock | Grant | Acquire A | No | No | 0 | 955 | 0.00 | 21,406 |
15 May 23 | Barrett Peter | Common Stock | Grant | Acquire A | No | No | 0 | 783 | 0.00 | 20,451 |
News
Analyst Ratings for Revvity
15 May 23
Citigroup Maintains Buy on Revvity, Lowers Price Target to $160
15 May 23
Stifel Maintains Hold on Revvity, Lowers Price Target to $135
12 May 23
Baird Maintains Outperform on Revvity, Lowers Price Target to $165
12 May 23
Barclays Maintains Equal-Weight on Revvity, Lowers Price Target to $125
12 May 23
Press releases
Revvity Announces Financial Results for the First Quarter of 2023
11 May 23
Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
9 May 23
Ares Management Corporation Announces U.S. Direct Lending Origination Activity for the First Quarter and Last Twelve Months 2023
28 Apr 23
PerkinElmer Board Declares Quarterly Dividend
25 Apr 23
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
12 Apr 23